Use of cetuximab in a real-life setting in France with respect to KRAS status: Preliminary results of EREBUS cohort study.
D. Smith
No relevant relationships to disclose
M. Rouyer
No relevant relationships to disclose
E. Francois
No relevant relationships to disclose
E. Mitry
No relevant relationships to disclose
A. Monnereau
No relevant relationships to disclose
A. Sa Cunha
No relevant relationships to disclose
E. Bignon
No relevant relationships to disclose
A. Le Monies
No relevant relationships to disclose
N. Moore
No relevant relationships to disclose
A. Fourrier-Réglat
No relevant relationships to disclose